Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Kobayashi, Seiju ^a   Tateno, Masaru ^a   Park, Tae Woo ^a   Utsumi, Kumiko ^b   Sohma, Hitoshi ^a,c   Ito, Yoichi M ^d   Kokai, Yasuo ^a   Saito, Toshikazu ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SUNAGAWA CITY MEDICAL CENTER   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PROTEIN EXPRESSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ASIAN; CASE CONTROL STUDY; GENETICS; JAPAN; MIDDLE AGED;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; LEWY BODY DISEASE; MALE; MIDDLE AGED;

EID: 79955727261     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018569     Document Type: Article

References (41)

1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
2. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
3. Mahley RW, (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630.
4. Dietschy JM, Turley SD, (2004) Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45: 1375-1397.
5. Strittmatter WJ, Roses AD, (1996) Apolipoprotein E and Alzheimer's disease. Annu Rev Neurosci 19: 53-77.
6. McKeith I, O'Brien J, (1999) Dementia with Lewy bodies. Aust N Z J Psychiatry 33: 800-808.
7. AkatsuHiroyasu K, Hidehisa Yamagata, Daisuke Isojima, Ikuko Kondo, Takayuki Yamamoto, Tomoyuki Kida, Masatoshi Takeda, Tetsuro Miki, Kenji Kosaka, (2004) Increased incidence of dementia with Lewy bodies in patients carrying the ε4-allele of apolipoprotein E. Psychogeriatrics 4: 8.
8. Arai H, Higuchi S, Muramatsu T, Iwatsubo T, Sasaki H, et al. (1994) Apolipoprotein E gene in diffuse Lewy body disease with or without co-existing Alzheimer's disease. Lancet 344: 1307.
9. Galasko D, Saitoh T, Xia Y, Thal LJ, Katzman R, et al. (1994) The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 44: 1950-1951.
10. Singleton AB, Wharton A, O'Brien KK, Walker MP, McKeith IG, et al. (2002) Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies. Dement Geriatr Cogn Disord 14: 167-175.
11. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, et al. (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65: 1863-1872.
12. Yamaguchi M, Kokai Y, Imai S, Utsumi K, Matsumoto K, et al. (2010) Investigation of annexin A5 as a biomarker for Alzheimer's disease using neuronal cell culture and mouse model. J Neurosci Res 88: 2682-2692.
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
14. Matsuda H, (2010) [Neuroimaging for patients with Alzheimer disease in routine practice]. Brain Nerve 62: 743-755.
15. Kobayashi S, Tateno M, Utsumi K, Takahashi A, Morii H, et al. (2009) Two-layer appearance on brain perfusion SPECT in idiopathic normal pressure hydrocephalus: a qualitative analysis by using easy Z-score imaging system, eZIS. Dement Geriatr Cogn Disord 28: 330-337.
16. Kobayashi S, Tateno M, Utsumi K, Takahashi A, Saitoh M, et al. (2008) Quantitative analysis of brain perfusion SPECT in Alzheimer's disease using a fully automated regional cerebral blood flow quantification software, 3DSRT. J Neurol Sci 264: 27-33.
17. Tateno M, Kobayashi S, Saito T, (2009) Imaging improves diagnosis of dementia with lewy bodies. Psychiatry Investig 6: 233-240.
18. Tateno M, Kobayashi S, Shirasaka T, Furukawa Y, Fujii K, et al. (2008) Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies. Dement Geriatr Cogn Disord 26: 453-457.
19. Tateno M, Utsumi K, Kobayashi S, Takahashi A, Saitoh M, et al. (2008) Usefulness of a blood flow analyzing program 3DSRT to detect occipital hypoperfusion in dementia with Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry 32: 1206-1209.
20. Matsuda H, (2007) [Neurological diseases and SPECT-analysis using easy Z-score imaging system (eZIS)]. Brain Nerve 59: 487-493.
21. Takeuchi R, Sengoku T, Matsumura K, (2006) Usefulness of fully automated constant ROI analysis software for the brain: 3DSRT and FineSRT. Radiat Med 24: 538-544.
22. Kobayashi S, Tateno M, Morii H, Utsumi K, Saito T, (2009) Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies. Psychiatry Res 174: 76-80.
23. Hixson JE, Vernier DT, (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545-548.
24. Ueki A, Kawano M, Namba Y, Kawakami M, Ikeda K, (1993) A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 163: 166-168.
25. Yamanaka H, Kamimura K, Tanahashi H, Takahashi K, Asada T, et al. (1998) Genetic risk factors in Japanese Alzheimer's disease patients: alpha1-ACT, VLDLR, and ApoE. Neurobiol Aging 19: S43-46.
26. Brecht WJ, Harris FM, Chang S, Tesseur I, Yu GQ, et al. (2004) Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci 24: 2527-2534.
27. Kawanishi C, Suzuki K, Odawara T, Iseki E, Onishi H, et al. (1996) Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease. J Neurol Sci 136: 140-142.
28. Okuizumi K, Onodera O, Tanaka H, Kobayashi H, Tsuji S, et al. (1994) ApoE-epsilon 4 and early-onset Alzheimer's. Nat Genet 7: 10-11.
29. Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J, (1994) Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry 57: 1414-1416.
30. Dai XY, Nanko S, Hattori M, Fukuda R, Nagata K, et al. (1994) Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type. Neurosci Lett 175: 74-76.
31. Carrillo Garcia F, Gil Neciga E, Alberca R, Garcia-Solis D, Millan J, et al. (2008) [Apolipoprotein E4 in dementia with Lewy bodies]. Neurologia 23: 152-156.
32. Engelborghs S, Dermaut B, Goeman J, Saerens J, Marien P, et al. (2003) Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. J Neurol Neurosurg Psychiatry 74: 1148-1151.
33. Cummings JL, (2000) Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol Aging 21: 845-861.
34. Jacobs D, Sano M, Marder K, Bell K, Bylsma F, et al. (1994) Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology 44: 1215-1220.
35. Fujimori M, Imamura T, Yamashita H, Hirono N, Ikejiri Y, et al. (1998) Age at onset and visuocognitive disturbances in Alzheimer disease. Alzheimer Dis Assoc Disord 12: 163-166.
36. Imamura T, Takatsuki Y, Fujimori M, Hirono N, Ikejiri Y, et al. (1998) Age at onset and language disturbances in Alzheimer's disease. Neuropsychologia 36: 945-949.
37. Lane R, He Y, Morris C, Leverenz JB, Emre M, et al. (2009) BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline. Mov Disord 24: 392-400.
38. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E, (1992) Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 305: 673-678.
39. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, et al. (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278: 1349-1356.
40. Ishii K, Tamaoka A, Mizusawa H, Shoji S, Ohtake T, et al. (1997) Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease. Brain Res 748: 250-252.
41. Kosaka K, (1990) Diffuse Lewy body disease in Japan. J Neurol 237: 197-204.